Intranasal Dexmedetomidine as a rescue strategy for established postoperative delirium following loss of intravenous access: a case report - Summary - MDSpire

Intranasal Dexmedetomidine as a rescue strategy for established postoperative delirium following loss of intravenous access: a case report

  • By

  • Yingao Peng

  • Mingjin Liu

  • Jiafang Wang

  • July 7, 2026

  • 0 min

Share

Objective:

To explore the use of intranasal dexmedetomidine as a rescue therapy for established postoperative delirium (POD) in a patient who self-removed his IV access.

Approach:
  • Patient Description: A 70-year-old man with a history of cerebral infarction developed POD after urologic surgery. He exhibited agitation and self-removed his IV catheter.
  • Intervention: Intranasal dexmedetomidine was administered in a stepwise titration protocol totaling 100 μg after IV diazepam failed to provide relief.
Key Findings:
  • The patient transitioned from agitation to calm and entered sustained sleep within 1 hour after IN dexmedetomidine administration.
  • Mild bradycardia was observed, but no clinically significant respiratory depression occurred.
  • The CAM test result was negative on postoperative day 2, and the patient was discharged on postoperative day 4.
Interpretation:

IN dexmedetomidine may provide a safe, non-invasive option for managing established POD when IV access is unavailable.

Limitations:
  • The study is based on a single case report, limiting generalizability.
  • No formal baseline cognitive assessment was conducted preoperatively.
Conclusion:

IN dexmedetomidine may be an effective alternative for managing POD in patients without IV access.

Original Source(s)

Related Content